- Email: [email protected]
Transactions
450
J. CLERINX ETAL.
pound would probably be useless. Eflornithine cannot be considered a suitable alternative for melarsoprol in late stage rhodesiense trypanosomiasis. References Bacchi, C. J., Nathan, H. C., Livingston,T.,Valladares, G., Saric, M., Sayer, P. D., Njogu, A. R. & Clarkson, A. B. (1990). Differential susceptibility to DL-a-difluoromethylornithine in clinical isolates of Trypano~oma brucei rhodesiense. AntimicrobialAgents and Chemotherapy, 34, 1183-l 188. Dales, J. D., Harrison, S. M. & Mwabi, D. L. (1989). Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya. Annals of Tropical Medicine and Parasitology, 83, supplement 1, 11 l-l 14. Iten, M., Met, H., Evans, A., Engau, J. C., Brun, R. & Kaminsky, R. (1997). Alteration in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to DL-a-difluoromethylornithine (DFMO). Anti-
1 Corrections
microbialAgents and Chemotherapy, 41, 1922-1925. Milord, F., Pepin, J., Loko, L., Ethier, L. & Mpia, B. (1992). Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness. Lancet, 340, 652-655. Taelman, H., Schechter, P. J., Marcelis, L., Sonnet, J., Kayumva, G., Dasnoy, J., Haegele, K. D., Sjoerdsma, A. &W&y, M. (1987). Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Results in five patients. American Journal of Medicine, 82, 607-614. Taelman, H., Clerinx, J., Bogaerts, J. & Vervoort, T. (1996). Combination treatment with suramin and eflornithine in late stage rhodesian trypanosomiasis: case report: Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 572-573.
Received 5 January 1998; revised 26 March 1998; accepted for publication 6 May 1998
1
The Partnership for Child Development. The health and nutritional status of schoolchildren in Africa: evidence from school-based health programmes in Ghana and Tanzania. Transactions, 92, 254-26 1. The name of Dr S. Tatala was inadvertently omitted from the list of principal investigators of theTanzania Partnership for Child Development, in the footnote on p. 254. A. Talbert et al. Spraying tick-infested houses with lambda-cyhalothrin reduces the incidence of tick-borne relapsing fever in children under five years old. Transactions, 92, 251-253. InTable 1 (p. 252), the heading of columns 6 and 7 should read ‘Total no. of ticks found’.
J. CLERINX ETAL.
pound would probably be useless. Eflornithine cannot be considered a suitable alternative for melarsoprol in late stage rhodesiense trypanosomiasis. References Bacchi, C. J., Nathan, H. C., Livingston,T.,Valladares, G., Saric, M., Sayer, P. D., Njogu, A. R. & Clarkson, A. B. (1990). Differential susceptibility to DL-a-difluoromethylornithine in clinical isolates of Trypano~oma brucei rhodesiense. AntimicrobialAgents and Chemotherapy, 34, 1183-l 188. Dales, J. D., Harrison, S. M. & Mwabi, D. L. (1989). Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya. Annals of Tropical Medicine and Parasitology, 83, supplement 1, 11 l-l 14. Iten, M., Met, H., Evans, A., Engau, J. C., Brun, R. & Kaminsky, R. (1997). Alteration in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to DL-a-difluoromethylornithine (DFMO). Anti-
1 Corrections
microbialAgents and Chemotherapy, 41, 1922-1925. Milord, F., Pepin, J., Loko, L., Ethier, L. & Mpia, B. (1992). Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness. Lancet, 340, 652-655. Taelman, H., Schechter, P. J., Marcelis, L., Sonnet, J., Kayumva, G., Dasnoy, J., Haegele, K. D., Sjoerdsma, A. &W&y, M. (1987). Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Results in five patients. American Journal of Medicine, 82, 607-614. Taelman, H., Clerinx, J., Bogaerts, J. & Vervoort, T. (1996). Combination treatment with suramin and eflornithine in late stage rhodesian trypanosomiasis: case report: Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 572-573.
Received 5 January 1998; revised 26 March 1998; accepted for publication 6 May 1998
1
The Partnership for Child Development. The health and nutritional status of schoolchildren in Africa: evidence from school-based health programmes in Ghana and Tanzania. Transactions, 92, 254-26 1. The name of Dr S. Tatala was inadvertently omitted from the list of principal investigators of theTanzania Partnership for Child Development, in the footnote on p. 254. A. Talbert et al. Spraying tick-infested houses with lambda-cyhalothrin reduces the incidence of tick-borne relapsing fever in children under five years old. Transactions, 92, 251-253. InTable 1 (p. 252), the heading of columns 6 and 7 should read ‘Total no. of ticks found’.